Form 4 Filing for Camp4 Therapeutics Corp

This filing details a transaction by Andrew J. Schwab, a director at Camp4 Therapeutics Corp, on August 3, 2026. Schwab acquired 3,179,558 shares through the exercise of a pre-funded warrant to purchase the company's common stock. The warrant, with an exercise price of $0.0001, is held by 5AM Ventures VII, L.P. The acquisition was executed at a price of $1.5299 per share. The pre-funded warrant has no expiration date, but its exercise is capped to prevent beneficial ownership from exceeding 9.99% of the company's outstanding common stock. Schwab, as a managing member of 5AM Partners VII, LLC, may be deemed to have shared voting and investment power over these shares, though he disclaims beneficial ownership beyond his pecuniary interest. This transaction is significant as it involves a director's acquisition of a substantial number of shares.